# Intra-nasal Ketorolac for Acute Ureteral Stent-associated Pain Following Ureteroscopy for Stone Disease

> **NCT06158620** · PHASE1,PHASE2 · RECRUITING · sponsor: **University of Texas Southwestern Medical Center** · enrollment: 80 (estimated)

## Conditions studied

- Post Operative Pain
- Urolithiasis
- Ureter Calculi
- Stent Complication

## Interventions

- **DRUG:** intra-nasal ketorolac
- **DRUG:** oral diclofenac

## Key facts

- **NCT ID:** NCT06158620
- **Lead sponsor:** University of Texas Southwestern Medical Center
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-03-01
- **Primary completion:** 2026-04-01
- **Final completion:** 2026-12-01
- **Target enrollment:** 80 (ESTIMATED)
- **Last updated:** 2025-04-18

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06158620

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06158620, "Intra-nasal Ketorolac for Acute Ureteral Stent-associated Pain Following Ureteroscopy for Stone Disease". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT06158620. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*